Locations:
SearchAdvertisement
New neoadjuvant treatment regimen offers hope to patients facing a poor prognosis
Emerging field enables treatment tailored to each patient
Some supplements associated with negative patient outcomes
Why most patients should explore clinical trials
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
ERAS practices lead to better pain management and fewer complications
Early screening, first-line therapy choice critical
Immune checkpoint inhibitor and oncolytic viral immunotherapy produce synergistic effect
Highlights from one of the most active therapeutic clinical trials programs in the U.S.
Treating a challenging cancer with novel use of radioembolization and SBRT
Number of brain metastases doesn’t matter for ALK/EGFR+ patients
Advertisement
Advertisement